U.S. Offers to Help China Curb “Covid Outbreak,” Including Vaccine Support
MarsBars/iStock/Getty Images Plus
Article audio sponsored by The John Birch Society

SINGAPORE — The United States has announced that it is prepared to aid China with its surging “Covid-19 outbreak,” cautioning that an unabated spread there may have consequences for the global economy.

“We’re prepared to continue to support countries around the world, including China, on this and other Covid-related health support,” State Department spokesman Ned Price said on Monday during a daily press briefing. “For us, this is not about politics, this is not about geopolitics.”

Asked if the United States had volunteered to offer China vaccines, Price said, “I’m not going to go into private discussions, but we’ve made the point many times publicly that we are the largest donor of Covid-19 vaccines around the world.”

China has eased its strict zero-Covid policy of lockdowns and testing after nationwide protests that severely impacted Chinese society and the economy.

Price reinforced Washington’s stance that it wants Beijing to overcome this outbreak not only for the sake of China, but for the rest of the world.

“We also note that what happens in China does have implications for the global economy,” he added.

The globalist World Health Organization (WHO) advisors, in their customary flip-flopping on Covid-19, said on Tuesday that it may be “too early” to announce the end of the “Covid-19 pandemic emergency phase” due to China’s upcoming wave.

Price, too, cautioned against a “new variant” developing from China’s “outbreak.”

“We also know that whenever the virus is spreading anywhere widely in an uncontrolled fashion, it has the potential for variants to emerge,” Price said.

In response to Price’s remarks, the Chinese Foreign Ministry said on Tuesday that China is regularly adjusting its measures to achieve a balance between epidemic prevention and control, and economic and social development.

China’s home-grown Sinopharm vaccine has an efficacy rate of 79 percent against symptoms and hospitalization after two doses, the pro-vaccine WHO reported in June, compared with (allegedly) 95 percent for U.S.-made Moderna and Pfizer “vaccines.” The WHO report clearly contradicts numerous reports of worldwide deaths and injuries due to the so-called vaccines, particularly the mRNA ones.

Also, eminent cardiologist and medical freedom advocate Dr. Peter McCullough, in a recent interview with LifeSiteNews, noted the dangers of Covid jabs and how Covid jab skeptics are still much better off never getting vaccinated. Recent months have seen numerous incidences of heart damage, blood clots, and neurological damage among the jabbed.

Meanwhile, on Wednesday, Berlin issued its first batch of BioNTech Covid-19 “vaccines” to China to be administered initially to German expatriates, a German government spokesman announced. This batch of BioNTech “vaccines” marks the first foreign coronavirus vaccine to be sent to China.

No further information was provided on the timing and size of the delivery, although the spokesman said Berlin is urging that foreigners besides German nationals in China, estimated at about 20,000, be granted access to the shot if they want it.

This shipment comes after China agreed to permit German nationals to get the shot following an agreement during Chancellor Olaf Scholz’s visit in Beijing last month, with the German leader asking Beijing to permit the shot to be made freely accessible to Chinese citizens as well.

In a letter to be issued to German citizens in mainland China, the government said it would offer basic immunizations and booster shots of vaccines authorized for use in the EU for free to anyone over 12 years of age.

Family members of other nationalities would not be included. Vaccinations for children under 12 may follow at a subsequent date.

“We are working on the possibility that besides Germans also other foreigners can be vaccinated with BioNTech,” the spokesman told journalists in Berlin.

In exchange, Chinese citizens in Europe can be vaccinated with China’s Sinovac, the spokesman added.

The shots will be sent to German companies in China as well as embassy locations, and talks are happening with other EU governments about giving them to citizens of other nationalities, a source acquainted with the situation said.

China would need to authorize expanding access beyond German nationals, the source said.

Previously, a report indicated that Germany’s health ministry had approved a permit for China’s Sinovac Covid vaccine to be imported to Germany to be administered to Chinese citizens in that country.

The Sinovac shot has not been authorized for use by Europe’s drug regulator, but the WHO has approved it.

Beijing has so far maintained its stance on using only domestically produced vaccines, which are not made according to the Western mRNA technology but on more traditional technologies.

German news magazine Der Spiegel also said that President Frank-Walter Steinmeier had offered Chinese leader Xi Jinping during a phone call on Tuesday help in tackling Covid-19, including supplying “hundreds of millions” of BioNTech “vaccines,” but that the gesture was declined.

Permitting German expatriates access to a Western “vaccine” is a big move from Beijing to Berlin as the former aims to better strengthen ties with the EU’s biggest economy after years of trade disputes.

China has nine domestically developed Covid-19 vaccines authorized for use, more than any other country. However, none of these vaccines were made to address the so-called Omicron variant. On the contrary, Big Pharma companies such as Pfizer-BioNTech and Moderna have boosters developed, despite the sheer number of deaths and injuries reportedly sustained due to their shots.

In the early stages of the Covid-19 outbreak, BioNTech inked an agreement with Shanghai Fosun Pharmaceutical with an aim to supply the shots to greater China.

Although the mRNA shots became accessible in Hong Kong, Macau, and Taiwan, the regulatory review for mainland China was not concluded up to the present day. BioNTech has said that decision was up to Chinese regulators and did not provide any reason for the delay.

China adheres to a narrow definition of Covid-19 deaths and reported no new fatalities for Tuesday, even removing one from its overall tally since the outbreak began.

The National Health Commission said that only deaths owing to pneumonia and respiratory failure in patients who had the virus are classified as Covid-19 deaths.